Physician profile
Reena B Patel
NPI 1821013830
$1,809.52
in general payments reported to CMS, 2019-2025
11 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.77 · 2023: $564 · 2024: $127 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256 · Travel and Lodging: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.86 |
| Travel and Lodging | $529.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $529.89 | 2023 | |
| Abbvie INC. | $310.13 | 2025 | |
| Davol INC. | $298.62 | 2025 | Surgiphor, Arista |
| Mentor Worldwide LLC | $242.50 | 2025 | Mentor Cpx 2 Breast Tissue Expander |
| Polynovo North America LLC | $205.97 | 2025 | Novosorb Btm |
| Solventum Corporation | $61.93 | 2024 | Activ.A.C., Prevena Restor Bellaform, V.A.C. Veraflo Cleanse Choice |
| Urgo Medical North America, LLC | $42.65 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Smith+Nephew, INC. | $37.27 | 2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $34.26 | 2023 | Durasorb Monofilament Mesh |
| Innovation Technologies INC | $23.77 | 2022 | |
| Axogen | $22.53 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.